Related references
Note: Only part of the references are listed.Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection
Henrique G. Colaco et al.
IMMUNITY (2021)
Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
Nilay Koese-Vogel et al.
CELLS (2020)
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Xiaohang Qiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
False discovery rates: a new deal
Matthew Stephens
BIOSTATISTICS (2017)
Modulation of inflammation and disease tolerance by DNA damage response pathways
Ana Neves-Costa et al.
FEBS JOURNAL (2017)
DNA-binding affinity and transcriptional activity of the RelA homodimer of nuclear factor B are not correlated
Maria Carmen Mulero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
NMR characterization of a 72 kDa transcription factor using differential isotopic labeling
Sulakshana P. Mukherjee et al.
PROTEIN SCIENCE (2016)
Kinetic characterization of small DNA-binding molecules interacting with a DNA strand on a quartz crystal microbalance
Hiroyuki Furusawa et al.
ANALYTICAL BIOCHEMISTRY (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
A small molecule-DNA binding landscape
Jonathan B. Chaires
BIOPOLYMERS (2015)
Chemical profiling of the genome with anti-cancer drugs defines target specificities
Baoxu Pang et al.
NATURE CHEMICAL BIOLOGY (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Doxorubicin Enhances Nucleosome Turnover around Promoters
Fan Yang et al.
CURRENT BIOLOGY (2013)
Anthracyclines Induce DNA Damage Response-Mediated Protection against Severe Sepsis
Nuno Figueiredo et al.
IMMUNITY (2013)
DNA Damage Sensing by the ATM and ATR Kinases
Alexandre Marechal et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host
Tetsuhiro Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Julie Millour et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36
Sergio Fernandes de Almeida et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
An shRNA-Based Screen of Splicing Regulators Identifies SFRS3 as a Negative Regulator of IL-1β Secretion
Pedro Moura-Alves et al.
PLOS ONE (2011)
Posttranslational modifications of NF-kappa B: Another layer of regulation for NF-kappa B signaling pathway
Bo Huang et al.
CELLULAR SIGNALLING (2010)
Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin
Torben Skovsgaard
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Kinetic enhancement of NF-κB•DNA dissociation by IκBα
Simon Bergqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Transcriptional control of the inflammatory response
Ruslan Medzhitov et al.
NATURE REVIEWS IMMUNOLOGY (2009)
A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome
Jinbao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Hypo-phosphorylation leads to nuclear retention of NF-κB p65 due to impaired IκBα gene synthesis
Karin Hochrainer et al.
FEBS LETTERS (2007)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
GATHER: a systems approach to interpreting genomic signatures
Jeffrey T. Chang et al.
BIOINFORMATICS (2006)
Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli (Publication with Expression of Concern. See vol. 371, pg. 1002, 2021)
ZH Wu et al.
SCIENCE (2006)
PIDD mediates NF-κB activation in response to DNA damage
S Janssens et al.
CELL (2005)
Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype
YW Eom et al.
ONCOGENE (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Nuclear Factor-κB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-κB-dependent transcription in cancer cells
WC Ho et al.
CANCER RESEARCH (2005)
Shaping the nuclear action of NF-κB
LF Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
The crystal structure of the complex between a disaccharide anthracycline and the DNA hexamer d(CGATCG) reveals two different binding sites involving two DNA duplexes
C Temperini et al.
NUCLEIC ACIDS RESEARCH (2003)
Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
A Arlt et al.
ONCOGENE (2001)
NF-κB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets
YQ Chen et al.
STRUCTURE WITH FOLDING & DESIGN (2000)
Share Paper
